nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.358	0.444	CbGaD
Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.252	0.313	CbGaD
Thioproperazine—HTR2A—attention deficit hyperactivity disorder	0.195	0.242	CbGaD
Thioproperazine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00603	0.15	CbGeAlD
Thioproperazine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00321	0.0797	CbGeAlD
Thioproperazine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00192	0.0476	CbGeAlD
Thioproperazine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00152	0.0377	CbGeAlD
Thioproperazine—DRD1—midbrain—attention deficit hyperactivity disorder	0.00127	0.0315	CbGeAlD
Thioproperazine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00125	0.0312	CbGeAlD
Thioproperazine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00116	0.0287	CbGeAlD
Thioproperazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.00113	0.0281	CbGeAlD
Thioproperazine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.00112	0.0277	CbGeAlD
Thioproperazine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.00108	0.0267	CbGeAlD
Thioproperazine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00106	0.0263	CbGeAlD
Thioproperazine—DRD1—nervous system—attention deficit hyperactivity disorder	0.00104	0.0259	CbGeAlD
Thioproperazine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.001	0.0249	CbGeAlD
Thioproperazine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000977	0.0243	CbGeAlD
Thioproperazine—ADRA1B—brain—attention deficit hyperactivity disorder	0.000853	0.0212	CbGeAlD
Thioproperazine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000828	0.0206	CbGeAlD
Thioproperazine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000824	0.0205	CbGeAlD
Thioproperazine—DRD1—brain—attention deficit hyperactivity disorder	0.000796	0.0198	CbGeAlD
Thioproperazine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000793	0.0197	CbGeAlD
Thioproperazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000748	0.0186	CbGeAlD
Thioproperazine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000747	0.0186	CbGeAlD
Thioproperazine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000681	0.0169	CbGeAlD
Thioproperazine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000655	0.0163	CbGeAlD
Thioproperazine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.00064	0.0159	CbGeAlD
Thioproperazine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000632	0.0157	CbGeAlD
Thioproperazine—SLC22A1—brain—attention deficit hyperactivity disorder	0.00063	0.0156	CbGeAlD
Thioproperazine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000627	0.0156	CbGeAlD
Thioproperazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000615	0.0153	CbGeAlD
Thioproperazine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000604	0.015	CbGeAlD
Thioproperazine—ALB—brain—attention deficit hyperactivity disorder	0.000603	0.015	CbGeAlD
Thioproperazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000592	0.0147	CbGeAlD
Thioproperazine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.00059	0.0147	CbGeAlD
Thioproperazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000579	0.0144	CbGeAlD
Thioproperazine—HTR1A—brain—attention deficit hyperactivity disorder	0.00052	0.0129	CbGeAlD
Thioproperazine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000493	0.0123	CbGeAlD
Thioproperazine—ADRA1A—brain—attention deficit hyperactivity disorder	0.00048	0.0119	CbGeAlD
Thioproperazine—DRD2—brain—attention deficit hyperactivity disorder	0.00047	0.0117	CbGeAlD
Thioproperazine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000406	0.0101	CbGeAlD
Thioproperazine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.00039	0.0097	CbGeAlD
Thioproperazine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000382	0.00948	CbGeAlD
Thioproperazine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000341	0.0381	CrCbGaD
Thioproperazine—HTR2A—brain—attention deficit hyperactivity disorder	0.00031	0.0077	CbGeAlD
Thioproperazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000233	0.0261	CrCbGaD
Thioproperazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000209	0.0234	CrCbGaD
Thioproperazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000206	0.023	CrCbGaD
Thioproperazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000197	0.022	CrCbGaD
Thioproperazine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.000197	0.022	CrCbGaD
Thioproperazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000191	0.0214	CrCbGaD
Thioproperazine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.000186	0.0208	CrCbGaD
Thioproperazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000164	0.0184	CrCbGaD
Thioproperazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000159	0.0178	CrCbGaD
Thioproperazine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000148	0.0165	CrCbGaD
Thioproperazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000143	0.016	CrCbGaD
Thioproperazine—Nefazodone—SLC6A3—attention deficit hyperactivity disorder	0.000139	0.0156	CrCbGaD
Thioproperazine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.000137	0.0153	CrCbGaD
Thioproperazine—Nefazodone—ADRA2A—attention deficit hyperactivity disorder	0.000136	0.0153	CrCbGaD
Thioproperazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000132	0.0148	CrCbGaD
Thioproperazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000128	0.0143	CrCbGaD
Thioproperazine—Thiothixene—DRD1—attention deficit hyperactivity disorder	0.000127	0.0142	CrCbGaD
Thioproperazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000127	0.0142	CrCbGaD
Thioproperazine—Trazodone—ADRA2A—attention deficit hyperactivity disorder	0.000126	0.0141	CrCbGaD
Thioproperazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.000125	0.014	CrCbGaD
Thioproperazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000124	0.0139	CrCbGaD
Thioproperazine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	0.000118	0.0132	CrCbGaD
Thioproperazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.000112	0.0126	CrCbGaD
Thioproperazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.000112	0.0125	CrCbGaD
Thioproperazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.00011	0.0123	CrCbGaD
Thioproperazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.000107	0.012	CrCbGaD
Thioproperazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.000106	0.0118	CrCbGaD
Thioproperazine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	0.000104	0.0116	CrCbGaD
Thioproperazine—Nefazodone—SLC6A4—attention deficit hyperactivity disorder	0.000104	0.0116	CrCbGaD
Thioproperazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.0114	CrCbGaD
Thioproperazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.000101	0.0113	CrCbGaD
Thioproperazine—Quetiapine—DRD4—attention deficit hyperactivity disorder	0.000101	0.0113	CrCbGaD
Thioproperazine—Trazodone—SLC6A4—attention deficit hyperactivity disorder	9.62e-05	0.0108	CrCbGaD
Thioproperazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	9.47e-05	0.0106	CrCbGaD
Thioproperazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	9.35e-05	0.0105	CrCbGaD
Thioproperazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	9.33e-05	0.0104	CrCbGaD
Thioproperazine—Promazine—DRD4—attention deficit hyperactivity disorder	9.26e-05	0.0104	CrCbGaD
Thioproperazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	9.22e-05	0.0103	CrCbGaD
Thioproperazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	9.05e-05	0.0101	CrCbGaD
Thioproperazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	8.97e-05	0.01	CrCbGaD
Thioproperazine—Thiothixene—DRD2—attention deficit hyperactivity disorder	8.97e-05	0.01	CrCbGaD
Thioproperazine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	8.95e-05	0.01	CrCbGaD
Thioproperazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	8.85e-05	0.00991	CrCbGaD
Thioproperazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	8.8e-05	0.00985	CrCbGaD
Thioproperazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	8.7e-05	0.00973	CrCbGaD
Thioproperazine—Quetiapine—DRD3—attention deficit hyperactivity disorder	8.69e-05	0.00972	CrCbGaD
Thioproperazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	8.57e-05	0.00959	CrCbGaD
Thioproperazine—Quetiapine—DRD1—attention deficit hyperactivity disorder	8.53e-05	0.00954	CrCbGaD
Thioproperazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	8.41e-05	0.0094	CrCbGaD
Thioproperazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	8.15e-05	0.00912	CrCbGaD
Thioproperazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	8.08e-05	0.00904	CrCbGaD
Thioproperazine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	8.04e-05	0.009	CrCbGaD
Thioproperazine—Nefazodone—HTR2A—attention deficit hyperactivity disorder	7.99e-05	0.00894	CrCbGaD
Thioproperazine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	7.92e-05	0.00886	CrCbGaD
Thioproperazine—Promazine—DRD1—attention deficit hyperactivity disorder	7.84e-05	0.00877	CrCbGaD
Thioproperazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	7.75e-05	0.00867	CrCbGaD
Thioproperazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	7.46e-05	0.00834	CrCbGaD
Thioproperazine—Trazodone—HTR2A—attention deficit hyperactivity disorder	7.4e-05	0.00828	CrCbGaD
Thioproperazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	7.28e-05	0.00815	CrCbGaD
Thioproperazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	7.21e-05	0.00807	CrCbGaD
Thioproperazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	7.13e-05	0.00798	CrCbGaD
Thioproperazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	7.03e-05	0.00786	CrCbGaD
Thioproperazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	6.93e-05	0.00776	CrCbGaD
Thioproperazine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	6.93e-05	0.00776	CrCbGaD
Thioproperazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	6.9e-05	0.00772	CrCbGaD
Thioproperazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	6.84e-05	0.00765	CrCbGaD
Thioproperazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	6.68e-05	0.00747	CrCbGaD
Thioproperazine—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.66e-05	0.000459	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.65e-05	0.000458	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.6e-05	0.000455	CbGpPWpGaD
Thioproperazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	6.59e-05	0.000454	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.52e-05	0.000449	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.52e-05	0.000449	CbGpPWpGaD
Thioproperazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	6.51e-05	0.00728	CrCbGaD
Thioproperazine—ADRA1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.49e-05	0.000447	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.44e-05	0.000444	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.41e-05	0.000442	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.41e-05	0.000442	CbGpPWpGaD
Thioproperazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	6.41e-05	0.00717	CrCbGaD
Thioproperazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	6.38e-05	0.00713	CrCbGaD
Thioproperazine—ADRA1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.34e-05	0.000437	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.34e-05	0.000436	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.31e-05	0.000435	CbGpPWpGaD
Thioproperazine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.29e-05	0.000433	CbGpPWpGaD
Thioproperazine—Promethazine—DRD2—attention deficit hyperactivity disorder	6.28e-05	0.00703	CrCbGaD
Thioproperazine—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.27e-05	0.000432	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.21e-05	0.000428	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.21e-05	0.000428	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.2e-05	0.000427	CbGpPWpGaD
Thioproperazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	6.2e-05	0.00693	CrCbGaD
Thioproperazine—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.19e-05	0.000426	CbGpPWpGaD
Thioproperazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	6.13e-05	0.00686	CrCbGaD
Thioproperazine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.09e-05	0.000419	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.08e-05	0.000419	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.06e-05	0.000417	CbGpPWpGaD
Thioproperazine—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	6.03e-05	0.000415	CbGpPWpGaD
Thioproperazine—Quetiapine—DRD2—attention deficit hyperactivity disorder	6.01e-05	0.00673	CrCbGaD
Thioproperazine—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.99e-05	0.000413	CbGpPWpGaD
Thioproperazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	5.99e-05	0.0067	CrCbGaD
Thioproperazine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.99e-05	0.000412	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.97e-05	0.000411	CbGpPWpGaD
Thioproperazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.91e-05	0.000407	CbGpPWpGaD
Thioproperazine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.91e-05	0.000407	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.89e-05	0.000406	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.87e-05	0.000404	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.87e-05	0.000404	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.85e-05	0.000403	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.82e-05	0.000401	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.79e-05	0.000399	CbGpPWpGaD
Thioproperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.77e-05	0.000397	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.77e-05	0.000397	CbGpPWpGaD
Thioproperazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	5.76e-05	0.00645	CrCbGaD
Thioproperazine—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.75e-05	0.000396	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.73e-05	0.000395	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.7e-05	0.000392	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.7e-05	0.000392	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.64e-05	0.000388	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.63e-05	0.000388	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.59e-05	0.000385	CbGpPWpGaD
Thioproperazine—Promazine—DRD2—attention deficit hyperactivity disorder	5.53e-05	0.00618	CrCbGaD
Thioproperazine—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.52e-05	0.00038	CbGpPWpGaD
Thioproperazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.49e-05	0.000378	CbGpPWpGaD
Thioproperazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	5.48e-05	0.00613	CrCbGaD
Thioproperazine—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.42e-05	0.000373	CbGpPWpGaD
Thioproperazine—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.33e-05	0.000367	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.32e-05	0.000367	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.31e-05	0.000365	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.26e-05	0.000362	CbGpPWpGaD
Thioproperazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	5.16e-05	0.00577	CrCbGaD
Thioproperazine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.15e-05	0.000355	CbGpPWpGaD
Thioproperazine—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.11e-05	0.000352	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.07e-05	0.000349	CbGpPWpGaD
Thioproperazine—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.07e-05	0.000349	CbGpPWpGaD
Thioproperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.06e-05	0.000349	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.06e-05	0.000349	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.98e-05	0.000343	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.96e-05	0.000342	CbGpPWpGaD
Thioproperazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	4.93e-05	0.00551	CrCbGaD
Thioproperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.88e-05	0.000336	CbGpPWpGaD
Thioproperazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	4.86e-05	0.00544	CrCbGaD
Thioproperazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	4.86e-05	0.00544	CrCbGaD
Thioproperazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	4.85e-05	0.00543	CrCbGaD
Thioproperazine—Imipramine—DRD2—attention deficit hyperactivity disorder	4.84e-05	0.00541	CrCbGaD
Thioproperazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	4.79e-05	0.00536	CrCbGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.74e-05	0.000327	CbGpPWpGaD
Thioproperazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	4.74e-05	0.0053	CrCbGaD
Thioproperazine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	4.65e-05	0.0052	CrCbGaD
Thioproperazine—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.61e-05	0.000317	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.6e-05	0.000317	CbGpPWpGaD
Thioproperazine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.58e-05	0.000316	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.58e-05	0.000315	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.57e-05	0.000315	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.56e-05	0.000314	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.52e-05	0.000312	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.48e-05	0.000309	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.48e-05	0.000309	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.42e-05	0.000305	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.4e-05	0.000303	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.39e-05	0.000303	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.37e-05	0.000301	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.36e-05	0.000301	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.36e-05	0.0003	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.35e-05	0.0003	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.31e-05	0.000297	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.3e-05	0.000296	CbGpPWpGaD
Thioproperazine—Promazine—HTR2A—attention deficit hyperactivity disorder	4.27e-05	0.00478	CrCbGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.21e-05	0.00029	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.18e-05	0.000288	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.15e-05	0.000286	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.14e-05	0.000285	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.12e-05	0.000284	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.07e-05	0.00028	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.05e-05	0.000279	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.02e-05	0.000277	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.02e-05	0.000277	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.97e-05	0.000274	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.96e-05	0.000272	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.95e-05	0.000272	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.93e-05	0.000271	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.92e-05	0.00027	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.91e-05	0.000269	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.87e-05	0.000267	CbGpPWpGaD
Thioproperazine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.86e-05	0.000266	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.85e-05	0.000265	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.85e-05	0.000265	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.85e-05	0.000265	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.83e-05	0.000264	CbGpPWpGaD
Thioproperazine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.82e-05	0.000263	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.82e-05	0.000263	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.8e-05	0.000262	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	3.78e-05	0.00026	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.78e-05	0.00026	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.76e-05	0.000259	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.76e-05	0.000259	CbGpPWpGaD
Thioproperazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	3.76e-05	0.0042	CrCbGaD
Thioproperazine—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.75e-05	0.000258	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.74e-05	0.000258	CbGpPWpGaD
Thioproperazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	3.74e-05	0.00418	CrCbGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.73e-05	0.000257	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.72e-05	0.000256	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.68e-05	0.000254	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.67e-05	0.000253	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.67e-05	0.000253	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.67e-05	0.000253	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.62e-05	0.00025	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.6e-05	0.000248	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.56e-05	0.000245	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.55e-05	0.000245	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.54e-05	0.000244	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.000241	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.5e-05	0.000241	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.000241	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.47e-05	0.000239	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.46e-05	0.000238	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.45e-05	0.000238	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.44e-05	0.000237	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.42e-05	0.000236	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.41e-05	0.000235	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.4e-05	0.000234	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000233	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000233	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.38e-05	0.000233	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.38e-05	0.000233	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.38e-05	0.000233	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.34e-05	0.00023	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.34e-05	0.00023	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.32e-05	0.000229	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.32e-05	0.000228	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000227	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000226	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.27e-05	0.000225	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.26e-05	0.000225	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.26e-05	0.000224	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.23e-05	0.000222	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.22e-05	0.000222	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.22e-05	0.000222	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.2e-05	0.00022	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.17e-05	0.000219	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.12e-05	0.000215	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.11e-05	0.000214	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.11e-05	0.000214	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.07e-05	0.000212	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.07e-05	0.000212	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.07e-05	0.000211	CbGpPWpGaD
Thioproperazine—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.06e-05	0.000211	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.06e-05	0.000211	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.03e-05	0.000209	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.02e-05	0.000208	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	3.01e-05	0.000207	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.01e-05	0.000207	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.01e-05	0.000207	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3e-05	0.000207	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.98e-05	0.000206	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.96e-05	0.000204	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.96e-05	0.000204	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.92e-05	0.000201	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.92e-05	0.000201	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.89e-05	0.000199	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.78e-05	0.000192	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.75e-05	0.00019	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.72e-05	0.000188	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.72e-05	0.000187	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.67e-05	0.000184	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.62e-05	0.000181	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.54e-05	0.000175	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.48e-05	0.000171	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.44e-05	0.000168	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.41e-05	0.000166	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.4e-05	0.000166	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.37e-05	0.000163	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.36e-05	0.000163	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.35e-05	0.000162	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.34e-05	0.000161	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.31e-05	0.000159	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.29e-05	0.000158	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.26e-05	0.000156	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.25e-05	0.000155	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.22e-05	0.000153	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.21e-05	0.000152	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.18e-05	0.00015	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.17e-05	0.00015	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.15e-05	0.000148	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.1e-05	0.000145	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.1e-05	0.000145	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.07e-05	0.000142	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.07e-05	0.000142	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.05e-05	0.000141	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.04e-05	0.000141	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.02e-05	0.000139	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	2.01e-05	0.000139	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.01e-05	0.000139	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2e-05	0.000138	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	1.98e-05	0.000137	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.98e-05	0.000136	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.98e-05	0.000136	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.97e-05	0.000136	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.94e-05	0.000134	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.91e-05	0.000131	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.91e-05	0.000131	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.9e-05	0.000131	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.88e-05	0.000129	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.85e-05	0.000127	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.84e-05	0.000127	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.84e-05	0.000126	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	1.82e-05	0.000126	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000125	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.81e-05	0.000125	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.81e-05	0.000125	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.81e-05	0.000125	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.79e-05	0.000123	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.79e-05	0.000123	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.78e-05	0.000123	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.76e-05	0.000121	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.75e-05	0.00012	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.73e-05	0.000119	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.64e-05	0.000113	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.61e-05	0.000111	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.61e-05	0.000111	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.55e-05	0.000107	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.53e-05	0.000106	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.33e-05	9.17e-05	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	1.29e-05	8.89e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.27e-05	8.74e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	1.22e-05	8.41e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	1.21e-05	8.35e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.18e-05	8.1e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.17e-05	8.05e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.13e-05	7.76e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.2e-06	5.65e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	7.82e-06	5.39e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.06e-06	4.86e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.72e-06	4.63e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.19e-06	4.27e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.1e-06	4.2e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.97e-06	4.11e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	5.23e-06	3.61e-05	CbGpPWpGaD
